Healthcare platform secures £1.25m in funding round and seeks larger premises
A health platform focused on prevention, early intervention and addressing health inequalities has raised £1.25m in a funding round from multiple funds.
The proceeds will be used to expand its team and accelerate the reach of its technology across the UK and Europe, and working with the Department of Business & Trade to source a larger premises.
A corporate spinout led by CEO Samantha Fay with its operations and logistics based in Manchester, SiSU provided data sets to local authorities, the NHS and employers, SiSU Health facilitates the delivery of wider health and economic benefit, and through the early detection of risk factors, such as high blood pressure and obesity, in order to encourage healthier lifestyle changes.
The investment has been secured from the GMC Life Sciences Fund By Praetura, which comprises Bruntwood SciTech, Greater Manchester Combined Authority and Enterprise Cheshire and Warrington. Investment has also come from NPIF II – Praetura Equity Finance, which is also managed by Praetura as part of The Northern Powerhouse Investment Fund II.
SiSU’s portfolio of clients includes Aldi, Jaguar Land Rover, The AA, Workday and a range of council and NHS Trust clients, and was part of the delivery of the Department of Health and Social Care funded CVD Workforce Health Check Program and plans to launch a new Public Health proposition to the market later this year.
Samantha Fay, CEO at SiSU Health, said: “We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers.”
The deal is the fifth deal the two funds have co-invested on in the last 12 months, with the funds aiming to boost the impact they’re having on the North West’s life sciences ecosystem by working in collaboration.
Sim Singh-Landa, head of the GMC Life Sciences Fund By Praetura, said: “SiSU Health is bringing health into the modern age by helping individuals to take a health test at a time that’s convenient to them without judgement and the costs that can be associated with health checks. They are critically providing connected collaboration between the corporate world and public health systems, encouraging self-care and health awareness for individuals with supported follow-up and interventions, which has significant benefits for the NHS and public health. This latest co-investment between the GMC Life Sciences Fund By Praetura and NPIF II also shows the power of two well-established regional funders working together to help propel great companies in the region.”
Sue Barnard, Senior Investment Manager at British Business Bank, said a key aim of The Northern Powerhouse Investment Fund II is to invest in businesses that are paving the way in innovation and creating valuable solutions for the people it serves. “It’s clear that the UK needs new solutions for healthcare issues and now, with the help of NPIF II funding, another great Northern business has secured the financial support it needs to help make this possible,” she said.
Praetura was advised by Manchester-based DWF Law LLP with Irwin Mitchell LLP supporting SiSU Health.
Pictured above, caption L-R: Sim Singh-Landa (head of the GMC Life Sciences Fund By Praetura), Sue Barnard (Senior Investment Manager at British Business Bank), Laurence Tan (Investment Associate at Praetura Ventures), Dr Kath Mackay (Chief Scientific Officer at Bruntwood SciTech) and Samantha Fay (CEO of SiSU Health).
